On Cancer

and/or

81 Blog posts found

Finding

Discovery of Unusual Cell Type Could Help Guide Immunotherapy

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.

Roundup

Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.

Crowded hall with ASCO signage

In the Lab

Study Identifies New Way to Combat a Serious CAR T Cell Therapy Side Effect

By uncovering the root cause of cytokine release syndrome, MSK researchers have found a way to stop it.

An illustration showing the process of CAR T cell therapy

In the Clinic

CAR Therapy for Solid Tumors Passes Early Milestone

Preliminary results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

Immunofluorescence staining of human lung cancer showing mesothelin (pink) on cancer cells and human T cells (green).

Roundup

Highlights from MSK at the 2018 American Association for Cancer Research Meeting

Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.

Sign for AACR scientific meeting featuring collage of images

In the Clinic

Immunotherapy Combination Is Better than Chemotherapy for Non-Small Cell Lung Cancer

MSK’s Matthew Hellmann led an international, phase III trial looking at the combination of immunotherapy drugs ipilimumab and nivolumab.

MSK medical oncologist Matthew Hellmann

In the Clinic

Immunotherapy Drug Shows Promise for Metastatic Merkel Cell Carcinoma

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.

Dermatologist examining skin on the face of older man.

In the Clinic

Getting the Most from Bladder Cancer Immunotherapy Drugs

Bladder cancer is more likely to respond to immunotherapy drugs if the tumors carry mutations in DNA repair genes.

Colored transmission electron micrograph (TEM) of a bladder cancer cell stained orange. The cell is large and has many nuclei (purple).

In the Clinic

Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

For adults with chemotherapy-resistant leukemia, CAR T cell therapy can be a lifesaving treatment option. New results suggest how to make it safer.

Medical oncologist Jae Park

Q&A

Immunotherapy Offers New Strategy for Treating Sarcoma

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.

Enlarged microscopic image of blue-green immune cells surrounding one blue cancer cell.